Selective PPARgamma antagonist (IC50 = 3.3, 32 and 2000 nM for PPARgamma, PPARalpha and PPARdelta respectively)1. Blocks the inhibition of osteoclast formation induced by IL-4 (1-2 µM)2. Displays anticancer activity inhibits growth of human mammary tumor cell lines3. A
* VAT and and shipping costs not included. Errors and price changes excepted